Top Pharma Companies in India by Market Cap

With reference to its letter no. KDL/SE/032/2026-27 dated August 18, 2026, Krsnaa Diagnostics has informed that it enclosed the Postal Ballot Notice dated August 13, 2026 (‘Notice’) for seeking approval of the shareholders of the Company on special resolution: Approval for Issuance of up to 16,21,000 Warrants Convertible into Equity Shares of Face Value Rs.5/- each on a Preferential Basis to the Promoter and Promoter Group of the Company.  Pursuant to Sections 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) read with the Companies (Management and Administration) Rules, 2014, guidelines prescribed by the Ministry of Corporate Affairs through various Circular(s) and the Listing Regulations, as amended from time to time, the Postal Ballot was conducted through remote e-voting process. The remote e-voting process concluded on Thursday, September 17, 2026, at 17:00 Hrs. (IST), post which Dinesh Shivnarayan Birla (Membership No.: FCS-7658, COP: 13029), Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, Company Secretaries, Scrutinizer submitted the Report on the Postal Ballot voting results on September 18, 2026. Based on the Scrutinizer’s Report, the company has informed that the Special Resolution mentioned in the Postal Ballot Notice dated August 13, 2026 has been passed by the Members of the Company with requisite majority on September 17, 2026, i.e., the last date of remote e-voting. In connection with the above, it has enclosed the following: a. Voting results pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Act read with the Companies (Management and Administration) Rules, 2014; and b. Scrutinizer's Report dated September 18, 2026 on remote e-voting.

The above information is a part of company’s filings submitted to BSE.